Skip to content
Recall Observatory FDA recall evidence

Drug product

Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.

D-0748-2022

April 01, 2022

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc
Event
Event 89906
Status
Terminated
Classification
Class II
Quantity
20,112 bottles
Official record key
drug-enforcement:D-0748-2022

Official wording

Reason: Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.

Code information: Lot # TV11W101, Exp Mar 2023

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent